By CARE
DIL announced that there has been an upgrade in Credit Rating assigned to Fermenta Biotech, Company's subsidiary, by CARE Ratings with effect from 10 January 2019. The rating also takes into account the impact of the proposed amalgamation of Fermenta Biotech with the Company. Consequently, the outlook has also been changed from credit watch with developing implications to stable.Long-term Bank Facilities (fund based limit) - CARE A-; Stable (Revised from CARE BBB+; under Credit watch with developing implications)
Long-term Bank Facilities (term loan) - CARE A-; Stable (Revised from CARE BBB+; under Credit watch with developing implications)
Short-term Bank Facilities (non-fund based limit) - CARE A2 (Revised from CARE A3+; under Credit watch with developing implications)
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
